Navigation Links
Latest Sleep Disorder Technology Tested With SleepQuest
Date:9/4/2008

SAN CARLOS, Calif., Sept. 4 /PRNewswire/ -- SleepQuest has partnered with ResMed, a leading manufacturer of medical equipment for sleep-disordered breathing, to conduct clinical trials of a new wireless technology used to monitor patients with Obstructive Sleep Apnea from wherever they are sleeping. The technology is intended to more easily provide data that can be used to improve the quality of care for those requiring PAP treatment.

"We take pride in working with companies on the cutting edge of technology," said Robert Koenigsberg, President/CEO of SleepQuest. "We want to deploy that expertise on behalf of our patients."

Employing Bluetooth technology, sleep data transmits instantly from a CPAP or other medical device to SleepQuest's Sleep Care Specialists, allowing them to monitor adherence that can increase treatment efficacy. This improves patient comfort, ensures better compliance, and reduces need for office visits or in-person device adjustments.

A total of 30 SleepQuest sleep apnea patients are currently participating in the trial. These patients report that the technology is easy to use and presents no technical problems, improving patient convenience by reducing the need for office visits to download data.

ResMed selected SleepQuest to lead this initiative because of their proven disease management approach for Obstructive Sleep Apnea and industry-leading treatment compliance rate.

"Ensuring that patients properly manage their condition through nightly CPAP treatment is our main goal," said Cody Parker, Regional Office Manager "Helping ResMed develop this wireless technology will benefit our patients by making CPAP treatment more comfortable and effective."

SleepQuest has found that without continued support and encouragement, many patients stop treatment after a few weeks. Their Continuum of Care program was developed in response: a step-by-step approach to diagnose and treat sleep apnea with thorough clinical and home support. The result is a patient therapy compliance rate of approximately 90%, compared to the industry average of about 50%.

"We are always looking for ways to provide convenient treatment and follow-up care for our patients," Parker said. "Immediate data transfer allows us to serve our patients more efficiently, saving them time and money."

For more than 10 years, SleepQuest has established itself as a leader in home testing and treatment of sleep apnea. To talk to a SleepQuest representative about treating sleep disorders call 800-813-8358 or email contact@sleepquest.com.


'/>"/>
SOURCE SleepQuest
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Varian Medical Systems Exhibits Latest Technologies and Products Designed to Improve Speed and Precision of Radiotherapy at ESTRO 2007
2. UD researchers race ahead with latest spintronics achievement
3. Digital Healthcare Announces Cincinnati Eye Institute is Latest Retasure Reading Center
4. 49th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases
5. Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3)
6. PacifiCare Capitulates to Latest Patient Revolt
7. Parks Associates Digital Health Analyst to Present Latest Research and Forecasts at ATA Show
8. Carbon nanotube measurements: latest in NIST how-to series
9. Rudd Report Highlights AMDL, Inc.s Latest Business Achievements; Supports 2008 Financial Guidance
10. [video] Jacques Tizabi, CEO of Universal Detection Technology Discusses Latest Purchase Order on WallSt.nets 3-Minute Press Show
11. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):